Found: 76
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17523, doi. 10.1002/cam4.4879
- Publication type:
- Article
Multiparametric MRI‐based model for prediction of local progression of hepatocellular carcinoma after thermal ablation.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17529, doi. 10.1002/cam4.6277
- By:
- Publication type:
- Article
Correspondence on "Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta‐analysis".
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17541, doi. 10.1002/cam4.6353
- By:
- Publication type:
- Article
Reply to the correspondence on salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta‐analysis.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Preoperative alkaline phosphatase‐to‐platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17545, doi. 10.1002/cam4.6368
- By:
- Publication type:
- Article
The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17559, doi. 10.1002/cam4.6369
- By:
- Publication type:
- Article
Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17569, doi. 10.1002/cam4.6374
- By:
- Publication type:
- Article
Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17581, doi. 10.1002/cam4.6376
- By:
- Publication type:
- Article
Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV‐associated cancers; a meta‐analysis on recurrent event endpoints.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17592, doi. 10.1002/cam4.6377
- By:
- Publication type:
- Article
Does COVID‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17603, doi. 10.1002/cam4.6378
- By:
- Publication type:
- Article
Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17613, doi. 10.1002/cam4.6379
- By:
- Publication type:
- Article
Protocol optimization of a targeted sequencing panel for genomic profiling of bronchoalveolar lavage fluid in lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17632, doi. 10.1002/cam4.6380
- By:
- Publication type:
- Article
A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17638, doi. 10.1002/cam4.6381
- By:
- Publication type:
- Article
Serum soluble immune checkpoint levels predict cervical lymph node metastasis of differentiated thyroid carcinoma patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17648, doi. 10.1002/cam4.6382
- By:
- Publication type:
- Article
The map of bone metastasis in nasopharyngeal carcinoma: A real‐world study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17660, doi. 10.1002/cam4.6383
- By:
- Publication type:
- Article
Values of tumor volume on magnetic resonance imaging for a surgical approach to endometrial cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17671, doi. 10.1002/cam4.6384
- By:
- Publication type:
- Article
Methods for the purification and detection of single nucleotide KRAS mutations on extrachromosomal circular DNA in human plasma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17679, doi. 10.1002/cam4.6385
- By:
- Publication type:
- Article
High‐intensity interval training in breast cancer patients: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17692, doi. 10.1002/cam4.6387
- By:
- Publication type:
- Article
The pathophysiology of cancer‐mediated cardiac cachexia and novel treatment strategies: A narrative review.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17706, doi. 10.1002/cam4.6388
- By:
- Publication type:
- Article
Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06).
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17718, doi. 10.1002/cam4.6390
- By:
- Publication type:
- Article
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR‐mutant non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17731, doi. 10.1002/cam4.6393
- By:
- Publication type:
- Article
Patient‐reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17740, doi. 10.1002/cam4.6394
- By:
- Publication type:
- Article
Interstitial lung abnormalities after hospitalization for COVID‐19 in patients with cancer: A prospective cohort study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17753, doi. 10.1002/cam4.6396
- By:
- Publication type:
- Article
Additional cytogenetic abnormalities in patients with newly diagnosed acute promyelocytic leukemia predict inferior event‐free survival.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17766, doi. 10.1002/cam4.6398
- By:
- Publication type:
- Article
Comprehensive analysis of predictive factors for upstaging in intraprostatic cancer after radical prostatectomy: Different patterns of spread exist in lesions at different locations.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17776, doi. 10.1002/cam4.6401
- By:
- Publication type:
- Article
Association of PD‐L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR‐mutated NSCLC.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17788, doi. 10.1002/cam4.6405
- By:
- Publication type:
- Article
Analysis of genetic factors associated with fatty liver disease‐related hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17798, doi. 10.1002/cam4.6410
- By:
- Publication type:
- Article
Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17808, doi. 10.1002/cam4.6412
- By:
- Publication type:
- Article
Aging characteristics of colorectal cancer based on gut microbiota.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17822, doi. 10.1002/cam4.6414
- By:
- Publication type:
- Article
Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17835, doi. 10.1002/cam4.6415
- By:
- Publication type:
- Article
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17849, doi. 10.1002/cam4.6416
- By:
- Publication type:
- Article
Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic function.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17856, doi. 10.1002/cam4.6418
- By:
- Publication type:
- Article
Effect of PIVKA‐II and AFP secretion status on early recurrence of hepatocellular carcinoma after open and laparoscopic surgery.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17866, doi. 10.1002/cam4.6422
- By:
- Publication type:
- Article
IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17878, doi. 10.1002/cam4.6423
- By:
- Publication type:
- Article
β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17891, doi. 10.1002/cam4.6424
- By:
- Publication type:
- Article
The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17901, doi. 10.1002/cam4.6425
- By:
- Publication type:
- Article
Post‐remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre‐ versus post‐VIALE‐A real‐world experience from a predominantly US community setting.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17914, doi. 10.1002/cam4.6430
- By:
- Publication type:
- Article
Meta‐analysis of PD‐(L)1 inhibitor plus chemotherapy versus chemotherapy as first‐line treatment in extensive‐stage small‐cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17924, doi. 10.1002/cam4.6433
- By:
- Publication type:
- Article
Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17934, doi. 10.1002/cam4.6434
- By:
- Publication type:
- Article
Conditional survival in breast cancer up to 10 years in the Nordic countries.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17945, doi. 10.1002/cam4.6436
- By:
- Publication type:
- Article
Identification of lymph node metastasis in pre‐operation cervical cancer patients by weakly supervised deep learning from histopathological whole‐slide biopsy images.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17952, doi. 10.1002/cam4.6437
- By:
- Publication type:
- Article
Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study).
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17967, doi. 10.1002/cam4.6438
- By:
- Publication type:
- Article
Population modeling of bosutinib exposure‐response in patients with newly diagnosed chronic phase chronic myeloid leukemia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17981, doi. 10.1002/cam4.6439
- By:
- Publication type:
- Article
Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17993, doi. 10.1002/cam4.6440
- By:
- Publication type:
- Article
Circulating hsa_circ_0072309, acting via the miR‐100/ACKR3 pathway, maybe a potential biomarker for the diagnosis, prognosis, and treatment of brain metastasis from non‐small‐cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18005, doi. 10.1002/cam4.6371
- By:
- Publication type:
- Article
Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18020, doi. 10.1002/cam4.6407
- By:
- Publication type:
- Article
Cancer‐associated fibroblasts nurture LGR5 marked liver tumor‐initiating cells and promote their tumor formation, growth, and metastasis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18032, doi. 10.1002/cam4.6408
- By:
- Publication type:
- Article
Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18050, doi. 10.1002/cam4.6411
- By:
- Publication type:
- Article
Increased RUNX3 expression mediates tumor‐promoting ability of human breast cancer‐associated fibroblasts.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18062, doi. 10.1002/cam4.6421
- By:
- Publication type:
- Article
UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18078, doi. 10.1002/cam4.6431
- By:
- Publication type:
- Article